News
News
-
Jun. 17, 2021
Info(Change of Disclosure Matters) Notice Concerning Internal Reorganization of Domestic Sales Functions through Company Split (Simple Absorption-type Split)
-
Jun. 04, 2021
InfoNotice Concerning Commencement of Consideration on Intra-Group Reorganization of Scientific Solutions Business
- Jun. 01, 2021 NROlympus Agrees on Transfer of its IT Solutions Subsidiary Company
- May. 28, 2021 NROlympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
-
May. 28, 2021
Info(Progress of disclosure matters) Notice Regarding Completion of Acquisition of Israeli medical device company Medi-Tate Ltd. (new subsidiary)
- May. 07, 2021 InfoFinancial Results
-
May. 07, 2021
InfoNotice Regarding Dividend of Retained Earnings
-
May. 07, 2021
InfoNotice Regarding Cancellation of Treasury Stock
- May. 06, 2021 NROlympus Targets Carbon Neutrality by 2030
-
Apr. 30, 2021
Info(Change of Disclosure Matters) Notice Regarding start of the process to acquire Israeli medical device company Medi-Tate Ltd. (new subsidiary) pursuant to its call option rights
New Products
Medical Systems
Endoscopes, Endosurgery, Endotherapy
Life Science Solutions
Advanced Imaging Solutions,
Biological Microscopes, Cell
Culture Solutions, Cameras,
Software, Optics & Accessories,
and OEM Components
Industrial Solutions
Non-Destructive Testing (NDT)
Instruments, XRF and XRD
Analyzers, Videoscopes,
Borescopes, and Industrial
Microscopes
